Centessa IPO Presentation Deck

MGX292: Key Data 200 MORPHOGEN-IX MGX292 reverses vascular lesions in rat Sugen-hypoxia model of Pulmonary Arterial Hypertension (PAH) Normal rat lung Sugen-hypoxia (7 weeks) Vascular lesions typical of PAH MGX292 Treatment 30 µg/kg (4 weeks) Disease reversal CENTESSA 27

View entire presentation